VT/VF/Heart Failure Summit
Wednesday, May 12 | 8:00 a.m. – 4:00 p.m.

This one-day summit has always been popular — don't miss this event, featuring a new format allowing greater interactivity between attendees and panel discussions!
Register TODAY »

The Summit will be divided into four sessions integrating expertise from four disciplines: VT ablation, basic science, devices and heart failure. Topics will include: mechanism of VT, heritable diseases of cardiac rhythm, what’s new in 2010, EP approach to the heart failure patient in the era of VADs, and primary ICD therapy in young patients.

VT/VF Heart Failure Summit with full Scientific Sessions registration (early, advance and on site) Members: (Physicians, Basic Scientists, Allied Professionals and Affiliates) $275 Non-Members: (Physicians, Basic Scientists, Allied Professionals, Fellows-in-Training, Exhibiting Company Personnel Attending Scientific Sessions, Exhibitor Conference and Undergraduate Students) $375 VT/VF Heart Failure Summit Only (early, advance and on site) Members: (Physicians, Basic Scientists and Allied Professionals) $475 Non-Members: (Physicians, Basic Scientists, Allied Professionals and Exhibiting Company Personnel NOT Attending Scientific Sessions and Undergraduate Students) $575 Affiliate Members: $275 Fellows-in-Training Non-members: $375

VT: From Basic Physiology to Clinical Management
8:00 – 9:45 a.m.

Session Description: A comprehensive evaluation of VT including basic mechanism and clinical management strategies.

Chairs:
Alfred E. Buxton, MD, Brown Medical School, Providence, RI
Stefan H. Hohnloser, MD, FHRS, J. W. Goethe University, Frankfurt, Germany

• Heart Rhythm Society Founders’ Lecture: Mechanism of VT: Insights from Intracardiac Recordings and Ablation
  Mark E. Josephson, MD, Beth Israel Deaconess Medical Center, Boston, MA
• Mechanism of VT: Insights from Cellular Physiology
  Charles Antzelevitch, Ph.D., FHRS, Masonic Medical Research Laboratory, Utica, NY
• Optimizing ICD Therapy to Treat VT
  Paul A. Friedman, MD, Mayo Clinic, Rochester, MN
• Ventricular Arrhythmias Contributing to Heart Failure
  Bruce Lerman, MD, FHRS, CCDS, Cornell University Medical Center, New York, NY

Break: 9:45 – 10:15 a.m.

Heritable Diseases of Cardiac Rhythm: What is New in 2010?
10:15 a.m. – 12:00 p.m.

Session Description: Participants will get an update in genetic advances and their role in understanding and managing heritable arrhythmic syndromes producing VT/VF and SCD.

Chairs:
Christine M. Albert, MD, Brigham and Women’s Hospital, Boston, MA
Stefan Kaab, MD, Ph.D., LMU Munich Klinikum Grosshadern, Munich, Germany

• Animal Models of Inherited Arrhythmias: Applications to Management of Human Disease
  Robert M. Shaw, MD, Ph.D., University of California San Francisco, CVRI and Medicine, San Francisco, CA
• Are Genetically-modified Induced Progenitor Cells (IPS) Useful for Human Studies of Heritable Arrhythmias?
  Lior Gepstein, MD, Ph.D., Technion Israel Institute of Technology, Haifa, Israel
• Do We Learn Anything from Studying 1,000, 100,000 or a Million Variants in the Human Genome about how to Manage Patients with Heritable Arrhythmias?
  Christopher Newton-Chen, MD, MPH, Harvard MEdical School, Boston MA
• Does My Patient with Aborted SCD Need Genetic Testing?
  Dan M. Roden, MD, Vanderbilt University School of Medicine, Nashville, TN

Lunch:
12:00 – 1:00 p.m. (Lunch provided to Summit attendees)

EP Approach to the Heart Failure Patient in the Era of Ventricular Assist Devices (VADs)
1:00–2:15 p.m.

Session Description: Topics to be addressed include: Recurrent VT, when to ablate, when to implant a VAD, when to transplant, use of the percutaneous VAD to support VT ablation procedures management of refractory VT in the heart failure patient, benefits and limitations of the left ventricular assist device pacing or use of the ICD to support the right heart and convert sustained arrhythmias in the setting of an implanted left ventricular assist device Interactions of VADs and implantable devices.

Chair: JoAnn Lindenfeld, MD, University of Colorado Health Sciences Center, Denver, CO

• CT Surgery
  Mark J. Cunningham, MD, USC Cardiothoracic Surgeons, Los Angeles, CA
• Heart Failure
  Lynne W. Stevenson, MD, Brigham and Women’s Hospital, Boston, MA
• EP
  John M. Miller, MD, Indiana University School of Medicine, Indianapolis, IN
• Case Presentations
  Michael Cao, MD, University of Southern California, Los Angeles, CA
• Basic Science Perspective
  Carlin S. Long, MD, University of Colorado, Denver, CO

Break: 2:15 – 2:45 p.m.

ICD Therapy in Young Patients
2:45 – 4:00 p.m.

Session Description: Discussion of the challenges of defibrillator therapy in young patients.

Chair: William J. Groh, MD, Krannert Institute of Cardiology, Indianapolis, IN
Matthew Taylor, MD, Ph.D., University of Colorado at Denver and Health Science, Aurora, CO

• Lamin Deficiency and Muscular Dystrophy
  Elizabeth McNally, MD, Ph.D., University of Chicago, IL
• Cosmetic Approaches to Device Implantation
  Peter H. Belott, MD, FHRS, Sharp Grossmont Hospital, El Cajon, CA
• SubQ Defibrillation
  Margaret A. Hood, MBChB, Auckland City Hospital, Auckland, New Zealand
• Pediatric ICD Therapy
  Charles I. Berul, MD, FHRS, CCDS, Children’s Hospital, Boston, MA
• Barriers to Conversations about Deactivation of ICDs in Seriously Ill Patients
  Nathan E. Goldstein, MD, Mount Sinai Medical Center, New York, NY
• Moderated Discussion
  William J. Groh, MD, Krannert Institute of Cardiology, Indianapolis, IN

Heart Rhythm 2010 Opening Plenary Session
4:15–5:45 p.m.

The Opening Plenary Session is Included with VT/VF/Heart Failure Summit registration fee.